[Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D006402:Hematologic Diseases / Q000209:etiology; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006834:Hydrazines; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
Résultats d'un nouvel essai de polychimiothérapie prolongée des cancers broncho-pulmonaires inopérables (à propos de 173 cas)